Healthcare of Ontario Pension Plan Trust Fund Invests $6.76 Million in Celanese Corporation $CE

Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in shares of Celanese Corporation (NYSE:CE - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 102,800 shares of the basic materials company's stock, valued at approximately $6,761,000. Healthcare of Ontario Pension Plan Trust Fund owned approximately 0.09% of Celanese at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of Celanese by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 11,840,341 shares of the basic materials company's stock valued at $500,610,000 after purchasing an additional 90,428 shares during the period. Capital Research Global Investors boosted its position in Celanese by 24.0% during the fourth quarter. Capital Research Global Investors now owns 5,565,556 shares of the basic materials company's stock worth $235,312,000 after purchasing an additional 1,076,645 shares in the last quarter. Turtle Creek Asset Management Inc. grew its holdings in Celanese by 21.0% in the third quarter. Turtle Creek Asset Management Inc. now owns 5,115,365 shares of the basic materials company's stock valued at $215,255,000 after purchasing an additional 887,600 shares during the period. Fuller & Thaler Asset Management Inc. raised its stake in shares of Celanese by 15.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 4,094,781 shares of the basic materials company's stock worth $173,127,000 after buying an additional 558,391 shares during the period. Finally, State Street Corp grew its stake in Celanese by 2.1% in the 4th quarter. State Street Corp now owns 3,949,230 shares of the basic materials company's stock valued at $166,973,000 after acquiring an additional 80,242 shares during the period. Hedge funds and other institutional investors own 98.87% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on CE shares. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a $60.00 price objective on shares of Celanese in a research note on Wednesday, July 22nd. UBS Group raised their target price on shares of Celanese from $58.00 to $64.00 and gave the stock a "neutral" rating in a research note on Thursday, April 9th. Morgan Stanley reduced their price objective on Celanese from $72.00 to $58.00 and set an "equal weight" rating on the stock in a research report on Thursday, July 16th. Zacks Research raised shares of Celanese from a "strong sell" rating to a "hold" rating in a research report on Tuesday, April 21st. Finally, Wall Street Zen downgraded shares of Celanese from a "buy" rating to a "hold" rating in a report on Saturday, June 20th. Ten analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $65.94.

Celanese Price Performance

CE stock opened at $43.94 on Thursday. The business has a 50 day simple moving average of $49.38 and a 200-day simple moving average of $54.03. The company has a market capitalization of $4.82 billion, a P/E ratio of -4.39, a PEG ratio of 0.27 and a beta of 0.76. Celanese Corporation has a twelve month low of $35.13 and a twelve month high of $70.70. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 2.41.

Celanese (NYSE:CE - Get Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The basic materials company reported $0.85 earnings per share for the quarter, missing analysts' consensus estimates of $0.88 by ($0.03). The business had revenue of $2.34 billion for the quarter, compared to analyst estimates of $2.34 billion. Celanese had a positive return on equity of 9.92% and a negative net margin of 11.54%.The firm's revenue for the quarter was down 2.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.57 EPS. Celanese has set its Q2 2026 guidance at 2.000-2.400 EPS. As a group, equities analysts anticipate that Celanese Corporation will post 6.01 EPS for the current year.

Celanese Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 10th. Shareholders of record on Tuesday, July 28th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Tuesday, July 28th. This represents a $0.12 annualized dividend and a yield of 0.3%. Celanese's dividend payout ratio is currently -1.20%.

About Celanese

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.